Candriam S.C.A. Eli Lilly & CO Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Eli Lilly & CO stock. As of the latest transaction made, Candriam S.C.A. holds 505,899 shares of LLY stock, worth $398 Million. This represents 2.62% of its overall portfolio holdings.

Number of Shares

505,899

Previous 485,616 4.18%

Holding current value

$398 Million

Previous $440 Million 1.94%

% of portfolio

2.62%

Previous 2.7%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $15.7 Million - $19.5 Million	20,283 Added 4.18%	505,899 $448 Million
Q2 2024 Aug 05, 2024	BUY	$724.87 - $909.04 $54.4 Million - $68.2 Million	75,079 Added 18.29%	485,616 $440 Million
Q1 2024 May 03, 2024	BUY	$592.2 - $792.28 $19.6 Million - $26.2 Million	33,025 Added 8.75%	410,537 $319 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $32.3 Million - $38 Million	61,449 Added 19.44%	377,512 $220 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $10.1 Million - $13.9 Million	-23,254 Reduced 6.85%	316,063 $170 Million
Q2 2023 Aug 08, 2023	SELL	$350.74 - $468.98 $50.9 Million - $68 Million	-145,090 Reduced 29.95%	339,317 $159 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $16.6 Million - $19.5 Million	-53,462 Reduced 9.94%	484,407 $166 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $3.57 Million - $4.16 Million	-11,094 Reduced 2.02%	537,869 $197 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $20.2 Million - $23.1 Million	68,254 Added 14.2%	548,963 $178 Million
Q2 2022 Aug 03, 2022	SELL	$278.73 - $327.27 $30.6 Million - $35.9 Million	-109,753 Reduced 18.59%	480,709 $156 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $16 Million - $19.9 Million	68,276 Added 13.08%	590,462 $169 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $86.5 Million - $107 Million	384,639 Added 279.64%	522,186 $144 Million
Q3 2021 Nov 09, 2021	BUY	$221.6 - $272.71 $3.49 Million - $4.3 Million	15,756 Added 12.94%	137,547 $31.8 Million
Q2 2021 Jul 20, 2021	SELL	$180.55 - $233.54 $14.3 Million - $18.4 Million	-78,944 Reduced 39.33%	121,791 $28 Million
Q4 2020 Jan 22, 2021	SELL	$130.46 - $172.63 $6.53 Million - $8.64 Million	-50,067 Reduced 19.96%	200,735 $33.9 Million
Q3 2020 Oct 19, 2020	SELL	$146.22 - $169.13 $5.73 Million - $6.63 Million	-39,221 Reduced 13.52%	250,802 $37.1 Million
Q2 2020 Jul 23, 2020	SELL	$136.42 - $164.18 $1.2 Million - $1.45 Million	-8,802 Reduced 2.95%	290,023 $47.6 Million
Q4 2019 Jan 21, 2020	BUY	$106.92 - $132.43 $3.05 Million - $3.78 Million	28,521 Added 10.55%	298,825 $39,000
Q3 2019 Oct 21, 2019	BUY	$106.79 - $116.16 $9.32 Million - $10.1 Million	87,250 Added 47.66%	270,304 $30,000
Q2 2019 Aug 01, 2019	BUY	$110.79 - $129.32 $227,119 - $265,106	2,050 Added 1.13%	183,054 $20.2 Million
Q1 2019 May 02, 2019	BUY	$111.31 - $131.02 $3.71 Million - $4.36 Million	33,302 Added 22.55%	181,004 $23.5 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $1.52 Million - $1.71 Million	-14,379 Reduced 8.87%	147,702 $17.1 Million
Q3 2018 Nov 07, 2018	SELL	$85.86 - $107.31 $8.83 Million - $11 Million	-102,872 Reduced 38.83%	162,081 $17.4 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $3.99 Million - $4.58 Million	-52,737 Reduced 16.6%	264,953 $22.6 Million
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $12.5 Million - $14.8 Million	-168,802 Reduced 34.7%	317,690 $24.6 Million
Q4 2017 Feb 07, 2018	BUY	$81.94 - $87.89 $4.59 Million - $4.93 Million	56,068 Added 13.03%	486,492 $41.1 Million
Q3 2017 Nov 03, 2017	BUY	$77.07 - $85.54 $33.2 Million - $36.8 Million	430,424	430,424 $36.8 Million

Others Institutions Holding LLY

# of Institutions

3,994

Shares Held

752M

Call Options Held

7.31M

Put Options Held

9.23M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $747B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account